News

NEWS

LATEST NEWS

Multiple viatmin D pills spilling out of a white jar

Pretreatment Vitamin D Deficiency Associated With Outcomes in Hodgkin Lymphoma

Organoids created from tumor samples have been revolutionizing laboratory research, but they also may begin helping oncologists decide on treatment regimens for patients.

Imaging Mass Cytometry Reveals Prognostic Immune Phenotypes in DLBCL

A recent meta-analysis including patients from 7 trials shows that MR improves overall survival amon

Durvalumab Adds No Benefit to Single-Agent Ibrutinib in FL, DLBCL

The approval of novel oral therapeutic agents may offer a more cost-effective treatment option for acute myeloid leukemia.

Modeling Lost Income and Life Expectancy Due to Sickle Cell Disease

The novel drug appeared effective in healthy, previously untreated patients, but cost, side effects, and other issues may stand in the way of its widespread use.

Outcomes Improved for Patients With AML and MDS Receiving Treosulfan/Fludarabine vs Busulfan/Fludarabine Conditioning Prior to HSCT

A paramedia works on a computer in a medical bay.

Even Slight Delays in CAR-T Therapy Administration May Increase Overall Mortality Rates

Some observational studies suggest that overweight BMI may have a protective effect during cancer tr

Monitoring Weight in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

UPCOMING MEETINGS

December 7 – 10, 2019
American Society of Hematology Annual Meeting and Exposition
Orlando, FL

Click here to view the full calendar

DRUG NEWS FROM MPR

Adakveo Approved for Sickle Cell Disease

FDA Grants Accelerated Approval to Brukinsa for Mantle Cell Lymphoma

Reblozyl Approved for Anemia in Beta Thalassemia

Gene Therapy Gets Orphan Drug Status for Gaucher Disease

Ultomiris Receives Approval for Atypical Hemolytic Uremic Syndrome

FDA Approves Earlier Use of Nplate in Immune Thrombocytopenia

FDA Approves Wilate for Hemophilia A in Adult and Adolescent Patients

Rivaroxaban Compared With Warfarin in Morbidly Obese Patients With VTE

Investigational Therapy for Hemophilia A Granted Orphan Drug Designation

New Treatment Option Approved for Patients With Myelofibrosis

Next post in News

A scientist examines a blood sample.

ASCT May Offer Alternative for Tx of High-Risk Follicular Lymphoma